Breaking News Instant updates and real-time market news.

BYD

Boyd Gaming

$31.37 /

+0.195 (+0.63%)

07:35
10/30/20
10/30
07:35
10/30/20
07:35

Boyd Gaming upgraded to Buy from Hold at Argus

Argus analyst John Staszak upgraded Boyd Gaming to Buy from Hold with a $36 price target. The company is benefiting from the recent acquisitions as well as from its cost-cutting efforts, the analyst tells investors in a research note. Staszak also sees Boyd's partnership with FanDuel and the expansion of its online betting platform as the company's "future growth drivers."

  • 02

    Nov

  • 11

    Nov

BYD Boyd Gaming
$31.37 /

+0.195 (+0.63%)

10/30/20 Argus
Boyd Gaming upgraded to Buy from Hold at Argus
10/28/20 Union Gaming
Union Gaming says 'better late than never,' upgrades Red Rock Resorts to Buy
10/27/20 Stifel
Boyd Gaming price target raised to $48 from $28 at Stifel
10/27/20 JPMorgan
Boyd Gaming price target raised to $49 from $43 at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
AGBA Acquisition enters term sheet for purchase of Platform Business of Convoy » 08:37
11/27/20
11/27
08:37
11/27/20
08:37
AGBA

AGBA Acquisition

$10.37 /

+0.07 (+0.68%)

AGBA Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Amazon to claim 42c of every e-commerce dollar spent, says Truist » 08:37
11/27/20
11/27
08:37
11/27/20
08:37
AMZN

Amazon.com

$3,185.20 /

+65.2 (+2.09%)

, GOOG

Alphabet

$1,771.55 /

+2.11 (+0.12%)

, GOOGL

Alphabet Class A

$1,765.50 /

+1.79 (+0.10%)

, FB

Facebook

$275.54 /

-1.295 (-0.47%)

, W

Wayfair

$250.63 /

+9.04 (+3.74%)

, TTD

Trade Desk

$862.28 /

+18.77 (+2.23%)

, SNAP

Snap

$45.57 /

+1.265 (+2.86%)

, PTON

Peloton

$106.77 /

+1.35 (+1.28%)

, EBAY

eBay

$50.47 /

-0.07 (-0.14%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

W Wayfair
$250.63 /

+9.04 (+3.74%)

TTD Trade Desk
$862.28 /

+18.77 (+2.23%)

SNAP Snap
$45.57 /

+1.265 (+2.86%)

PTON Peloton
$106.77 /

+1.35 (+1.28%)

EBAY eBay
$50.47 /

-0.07 (-0.14%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

08:23 Today MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
11/20/20 Credit Suisse
GoodRx price target lowered to $49 from $60 at Credit Suisse
GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/03/20 Citi
Alphabet Class A price target raised to $2,000 from $1,600 at Citi
11/02/20 Canaccord
Alphabet price target raised to $1900 from $1800 at Canaccord
10/30/20 Raymond James
Alphabet price target raised to $1,800 from $1,700 at Raymond James
GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

08:23 Today MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/03/20 Citi
Alphabet Class A price target raised to $2,000 from $1,600 at Citi
FB Facebook
$275.54 /

-1.295 (-0.47%)

08:23 Today MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
10/30/20 Raymond James
Facebook price target raised to $320 from $280 at Raymond James
10/30/20 Canaccord
Facebook price target raised to $330 from $315 at Canaccord
10/30/20 MKM Partners
Facebook price target raised to $330 from $300 at MKM Partners
W Wayfair
$250.63 /

+9.04 (+3.74%)

11/10/20
Fly Intel: Top five analyst upgrades
11/10/20 DA Davidson
Wayfair upgraded to Buy from Neutral at DA Davidson
11/05/20 Citi
Wayfair price target raised to $230 from $225 at Citi
11/04/20 DA Davidson
Wayfair price target raised to $280 from $260 at DA Davidson
TTD Trade Desk
$862.28 /

+18.77 (+2.23%)

11/23/20 Needham
Trade Desk price target raised to $1,000 from $750 at Needham
11/19/20 Berenberg
Trade Desk initiated with a Buy at Berenberg
11/10/20 Citi
Trade Desk price target raised to $760 from $510 at Citi
11/06/20 RBC Capital
Trade Desk price target raised to $715 from $510 at RBC Capital
SNAP Snap
$45.57 /

+1.265 (+2.86%)

11/19/20 Loop Capital
Snap price target raised to $49 from $27 at Loop Capital
11/12/20 Deutsche Bank
Snap price target raised to $48 from $40 at Deutsche Bank
10/29/20 Wedbush
Pinterest price target raised to $74 from $58.74 at Wedbush
10/23/20 Citi
Snap price target raised to $24 from $19 at Citi
PTON Peloton
$106.77 /

+1.35 (+1.28%)

11/12/20 Exane BNP Paribas
Peloton initiated with an Outperform at Exane BNP Paribas
11/10/20 Baird
Peloton weakness a buying opportunity, says Baird
11/09/20 Baird
Peloton weakness a buying opportunity, says Baird
11/06/20 MKM Partners
Peloton price target raised to $110 from $90 at MKM Partners
EBAY eBay
$50.47 /

-0.07 (-0.14%)

11/04/20 BMO Capital
PayPal price target lowered to $193 from $200 at BMO Capital
11/03/20 KeyBanc
PayPal price target lowered to $215 from $230 at KeyBanc
11/03/20 Morgan Stanley
PayPal growth potential looks even better after Q3, says Morgan Stanley
11/03/20 JPMorgan
PayPal selloff a buying opportunity, says JPMorgan
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

W Wayfair
$250.63 /

+9.04 (+3.74%)

TTD Trade Desk
$862.28 /

+18.77 (+2.23%)

SNAP Snap
$45.57 /

+1.265 (+2.86%)

PTON Peloton
$106.77 /

+1.35 (+1.28%)

EBAY eBay
$50.47 /

-0.07 (-0.14%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

W Wayfair
$250.63 /

+9.04 (+3.74%)

SNAP Snap
$45.57 /

+1.265 (+2.86%)

PTON Peloton
$106.77 /

+1.35 (+1.28%)

EBAY eBay
$50.47 /

-0.07 (-0.14%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

W Wayfair
$250.63 /

+9.04 (+3.74%)

TTD Trade Desk
$862.28 /

+18.77 (+2.23%)

SNAP Snap
$45.57 /

+1.265 (+2.86%)

PTON Peloton
$106.77 /

+1.35 (+1.28%)

EBAY eBay
$50.47 /

-0.07 (-0.14%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

GOOG Alphabet
$1,771.55 /

+2.11 (+0.12%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

W Wayfair
$250.63 /

+9.04 (+3.74%)

TTD Trade Desk
$862.28 /

+18.77 (+2.23%)

SNAP Snap
$45.57 /

+1.265 (+2.86%)

PTON Peloton
$106.77 /

+1.35 (+1.28%)

EBAY eBay
$50.47 /

-0.07 (-0.14%)

Recommendations
Signature Bank price target raised to $138 from $117 at Raymond James » 08:34
11/27/20
11/27
08:34
11/27/20
08:34
SBNY

Signature Bank

$115.35 /

-1.19 (-1.02%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBNY Signature Bank
$115.35 /

-1.19 (-1.02%)

11/16/20 Wedbush
Signature Bank added to Best Ideas List at Wedbush
11/12/20 BofA
Signature Bank and Werner added to Endeavor list at BofA
11/11/20 Credit Suisse
Signature Bank price target raised to $120 from $107 at Credit Suisse
10/21/20 Wedbush
Signature Bank price target lowered to $110 from $115 at Wedbush
SBNY Signature Bank
$115.35 /

-1.19 (-1.02%)

Hot Stocks
SuRo Capital says currently holds 80% of its pre-IPO Palantir Holdings » 08:34
11/27/20
11/27
08:34
11/27/20
08:34
SSSS

SuRo Capital

$12.14 /

+0.6 (+5.20%)

, PLTR

Palantir

$29.05 /

+5.22 (+21.91%)

SuRo Capital (SSSS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSSS SuRo Capital
$12.14 /

+0.6 (+5.20%)

PLTR Palantir
$29.05 /

+5.22 (+21.91%)

SSSS SuRo Capital
$12.14 /

+0.6 (+5.20%)

08/06/20 Barrington
SuRo Capital price target raised to $15 from $12 at Barrington
07/20/20 BTIG
SuRo Capital price target raised to $16 from $12 at BTIG
07/07/20 Barrington
SuRo Capital price target raised to $12 from $10 at Barrington
PLTR Palantir
$29.05 /

+5.22 (+21.91%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$29.05 /

+5.22 (+21.91%)

PLTR Palantir
$29.05 /

+5.22 (+21.91%)

SSSS SuRo Capital
$12.14 /

+0.6 (+5.20%)

PLTR Palantir
$29.05 /

+5.22 (+21.91%)

SSSS SuRo Capital
$12.14 /

+0.6 (+5.20%)

PLTR Palantir
$29.05 /

+5.22 (+21.91%)

Conference/Events
Infineon holds a business news update conference call » 08:33
11/27/20
11/27
08:33
11/27/20
08:33
IFNNY

Infineon

$0.00 /

+ (+0.00%)

Dr. Peter Wawer, Division…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IFNNY Infineon
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

11/10/20 Morgan Stanley
Infineon price target raised to EUR 30.50 from EUR 30 at Morgan Stanley
11/10/20 Deutsche Bank
Infineon price target raised to EUR 33 from EUR 27 at Deutsche Bank
11/05/20 Credit Suisse
Infineon price target raised to EUR 22.50 from EUR 19.20 at Credit Suisse
10/26/20 Morgan Stanley
Infineon price target raised to EUR 30 from EUR 25 at Morgan Stanley
IFNNY Infineon
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

Hot Stocks
Cassava says USAN modifies drug candidate's chemical name to simufilam » 08:32
11/27/20
11/27
08:32
11/27/20
08:32
SAVA

Cassava Sciences

$7.70 /

+0.42 (+5.77%)

Cassava Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVA Cassava Sciences
$7.70 /

+0.42 (+5.77%)

SAVA Cassava Sciences
$7.70 /

+0.42 (+5.77%)

10/22/20 Cantor Fitzgerald
Cassava Sciences initiated with an Overweight at Cantor Fitzgerald
09/23/20 H.C. Wainwright
Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright
09/14/20 Maxim
Cassava upgraded to Buy at Maxim after second analysis of AD drug data
09/14/20 Maxim
Cassava Sciences upgraded to Buy from Hold at Maxim
SAVA Cassava Sciences
$7.70 /

+0.42 (+5.77%)

  • 13
    Nov
SAVA Cassava Sciences
$7.70 /

+0.42 (+5.77%)

SAVA Cassava Sciences
$7.70 /

+0.42 (+5.77%)

Recommendations
Travelers price target raised to $160 from $140 at MKM Partners » 08:30
11/27/20
11/27
08:30
11/27/20
08:30
TRV

Travelers

$136.10 /

-0.32 (-0.23%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRV Travelers
$136.10 /

-0.32 (-0.23%)

TRV Travelers
$136.10 /

-0.32 (-0.23%)

11/17/20 Barclays
Travelers initiated with an Overweight at Barclays
10/29/20 BofA
Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed
10/21/20 Deutsche Bank
Travelers price target raised to $130 from $126 at Deutsche Bank
10/12/20 JPMorgan
Travelers downgraded to Underweight from Neutral at JPMorgan
TRV Travelers
$136.10 /

-0.32 (-0.23%)

TRV Travelers
$136.10 /

-0.32 (-0.23%)

Recommendations
Chubb price target raised to $180 from $150 at MKM Partners » 08:30
11/27/20
11/27
08:30
11/27/20
08:30
CB

Chubb

$152.56 /

-2.16 (-1.40%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CB Chubb
$152.56 /

-2.16 (-1.40%)

CB Chubb
$152.56 /

-2.16 (-1.40%)

11/24/20 Raymond James
Chubb upgraded to Strong Buy from Outperform at Raymond James
11/24/20 Raymond James
Chubb upgraded to Strong Buy from Outperform at Raymond James
11/17/20 Barclays
Chubb initiated with an Overweight at Barclays
11/10/20 Goldman Sachs
Chubb upgraded to Buy from Sell at Goldman Sachs
CB Chubb
$152.56 /

-2.16 (-1.40%)

CB Chubb
$152.56 /

-2.16 (-1.40%)

CB Chubb
$152.56 /

-2.16 (-1.40%)

CB Chubb
$152.56 /

-2.16 (-1.40%)

Options
Two new option listings and three option delistings on November 27th » 08:30
11/27/20
11/27
08:30
11/27/20
08:30
QS

QuantumScape

$23.05 /

+1.56 (+7.26%)

, GPOR

Gulfport Energy

/

+

, KCAC

Kensington Capital Acquisition

$0.00 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QS QuantumScape
$23.05 /

+1.56 (+7.26%)

GPOR Gulfport Energy
/

+

KCAC Kensington Capital Acquisition
$0.00 /

+ (+0.00%)

QS QuantumScape
$23.05 /

+1.56 (+7.26%)

GPOR Gulfport Energy
/

+

05/11/20 Imperial Capital
Gulfport Energy price target raised to $4 from $2 at Imperial Capital
04/03/20 Wells Fargo
Wells Fargo says oil markets heading into eye of 'perfect storm' in Q2
03/31/20 Stifel
Gulfport Energy downgraded to Sell from Buy at Stifel
03/25/20 JPMorgan
Gulfport Energy downgraded to Underweight from Neutral at JPMorgan
KCAC Kensington Capital Acquisition
$0.00 /

+ (+0.00%)

GPOR Gulfport Energy
/

+

QS QuantumScape
$23.05 /

+1.56 (+7.26%)

KCAC Kensington Capital Acquisition
$0.00 /

+ (+0.00%)

QS QuantumScape
$23.05 /

+1.56 (+7.26%)

KCAC Kensington Capital Acquisition
$0.00 /

+ (+0.00%)

GPOR Gulfport Energy
/

+

KCAC Kensington Capital Acquisition
$0.00 /

+ (+0.00%)

Recommendations
Axis Capital price target raised to $65 from $55 at MKM Partners » 08:29
11/27/20
11/27
08:29
11/27/20
08:29
AXS

Axis Capital

$52.64 /

-0.8 (-1.50%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

11/03/20 Deutsche Bank
Axis Capital price target raised to $44 from $42 at Deutsche Bank
04/01/20 Wells Fargo
Axis Capital price target lowered to $43 from $60 at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight from Equal Weight at Wells Fargo
AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

Recommendations
Salesforce deal for Slack would likely be dilutive, says Morgan Stanley » 08:26
11/27/20
11/27
08:26
11/27/20
08:26
CRM

Salesforce

$246.75 /

-13.96 (-5.35%)

, WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

Commenting on the The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

08:23 Today MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

Recommendations
Facebook, Google may also be interested in Slack, says MKM Partners » 08:23
11/27/20
11/27
08:23
11/27/20
08:23
WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

, GOOGL

Alphabet Class A

$1,765.50 /

+1.79 (+0.10%)

, FB

Facebook

$275.54 /

-1.295 (-0.47%)

, AMZN

Amazon.com

$3,185.20 /

+65.2 (+2.09%)

, MSFT

Microsoft

$213.78 /

-0.08 (-0.04%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/03/20 Citi
Alphabet Class A price target raised to $2,000 from $1,600 at Citi
11/02/20 Canaccord
Alphabet price target raised to $1900 from $1800 at Canaccord
FB Facebook
$275.54 /

-1.295 (-0.47%)

10/30/20 Raymond James
Facebook price target raised to $320 from $280 at Raymond James
10/30/20 Canaccord
Facebook price target raised to $330 from $315 at Canaccord
10/30/20 MKM Partners
Facebook price target raised to $330 from $300 at MKM Partners
10/30/20 Wedbush
Facebook price target raised to $320 from $300 at Wedbush
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
11/20/20 Credit Suisse
GoodRx price target lowered to $49 from $60 at Credit Suisse
11/19/20 Pivotal Research
Pivotal Research upgrades Roku to Hold with lead seeming sustainable
MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

Recommendations
Salesforce acquisition of Slack would 'make sense', says DA Davidson » 08:13
11/27/20
11/27
08:13
11/27/20
08:13
WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

, CRM

Salesforce

$246.75 /

-13.96 (-5.35%)

, AMZN

Amazon.com

$3,185.20 /

+65.2 (+2.09%)

, MSFT

Microsoft

$213.78 /

-0.08 (-0.04%)

DA Davidson analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/25/20 BMO Capital
Salesforce price target raised to $285 from $260 at BMO Capital
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
11/20/20 Credit Suisse
GoodRx price target lowered to $49 from $60 at Credit Suisse
11/19/20 Pivotal Research
Pivotal Research upgrades Roku to Hold with lead seeming sustainable
11/19/20 Credit Suisse
Credit Suisse remains bullish on Amazon ahead of quarterly results
MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/23/20 KeyBanc
Microsoft initiated with an Overweight at KeyBanc
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

Hot Stocks
Trident Acquisitions Corp. files poxy supplement on business combination » 08:10
11/27/20
11/27
08:10
11/27/20
08:10
TDAC

Trident Acquisitions Corp.

$11.09 /

+0.1 (+0.91%)

Trident Acquisitions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDAC Trident Acquisitions Corp.
$11.09 /

+0.1 (+0.91%)

Syndicate
Allena Pharmaceuticals files to sell 6.1M shares of common stock for holders  08:09
11/27/20
11/27
08:09
11/27/20
08:09
ALNA

Allena Pharmaceuticals

$1.39 /

+0.045 (+3.36%)

 
ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

Hot Stocks
Cypress Development announces extension to Nevada option agreement » 08:08
11/27/20
11/27
08:08
11/27/20
08:08
CYDVF

Cypress Development

$0.00 /

+ (+0.00%)

Cypress Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYDVF Cypress Development
$0.00 /

+ (+0.00%)

CYDVF Cypress Development
$0.00 /

+ (+0.00%)

Hot Stocks
SmartPharm awarded contract for development of countermeasure against COVID » 08:07
11/27/20
11/27
08:07
11/27/20
08:07
SRNE

Sorrento Therapeutics

$6.89 /

+0.105 (+1.55%)

SmartPharm Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

Hot Stocks
Scorpio Bulkers announces sale of Ultramax vessels for $67M » 08:05
11/27/20
11/27
08:05
11/27/20
08:05
SALT

Scorpio Bulkers

$16.19 /

+0.16 (+1.00%)

Scorpio Bulkers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

10/29/20
Scorpio Bulkers participates in a conference call hosted by B. Riley Securities
10/28/20 B. Riley Securities
Scorpio Bulkers price target lowered to $30 from $35 at B. Riley Securities
07/07/20 B. Riley FBR
Scorpio Bulkers price target lowered to $35 from $40 at B. Riley FBR
06/10/20 Stifel
Scorpio Bulkers price target lowered to $33 from $40 at Stifel
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

  • 10
    Jun
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

Initiation
O3 Mining initiated with a Speculative Buy at Cormark » 08:05
11/27/20
11/27
08:05
11/27/20
08:05
OQMGF

O3 Mining

$0.00 /

+ (+0.00%)

Cormark analyst Brock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OQMGF O3 Mining
$0.00 /

+ (+0.00%)

OQMGF O3 Mining
$0.00 /

+ (+0.00%)

09/16/20 CIBC
O3 Mining price target raised to C$6 from C$5 at CIBC
09/11/20 National Bank
O3 Mining price target raised to C$4.75 from C$3.50 at National Bank
08/28/20 Canaccord
Canaccord backs Speculative Buy on O3 Mining after Val d'Or results
05/21/20 CIBC
O3 Mining initiated with an Outperformer at CIBC
Hot Stocks
Genetron says HCCscreen selected by NCC, Wuxi for public health initiative » 08:04
11/27/20
11/27
08:04
11/27/20
08:04
GTH

Genetron

$13.30 /

+0.81 (+6.49%)

Genetron Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$13.30 /

+0.81 (+6.49%)

GTH Genetron
$13.30 /

+0.81 (+6.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$13.30 /

+0.81 (+6.49%)

  • 19
    Jun
GTH Genetron
$13.30 /

+0.81 (+6.49%)

Hot Stocks
Exelixis says Takeda receives approval for CABOMETYX in Japan » 08:03
11/27/20
11/27
08:03
11/27/20
08:03
EXEL

Exelixis

$18.74 /

+0.33 (+1.79%)

, TAK

Takeda Pharmaceutical

$17.72 /

+0.115 (+0.65%)

Exelixis (EXEL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

Hot Stocks
4D pharma files SEC forms to gain Nasdaq listing following Longevity merger » 08:01
11/27/20
11/27
08:01
11/27/20
08:01
LOAC

Longevity Acquisition Corporation

$11.08 /

+0.16 (+1.47%)

4D pharma announces the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOAC Longevity Acquisition Corporation
$11.08 /

+0.16 (+1.47%)

Initiation
Dye & Durham initiated with an Outperform at Raymond James » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
DYNDF

Dye & Durham

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYNDF Dye & Durham
$0.00 /

+ (+0.00%)

11/11/20 Canaccord
Dye & Durham price target raised to C$30 from C$28 at Canaccord
10/02/20 Scotiabank
Dye & Durham price target raised to C$27 from C$21 at Scotiabank
Options
Moderna call buyer realizes 22% same-day gains » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
MRNA

Moderna

$109.18 /

+10.54 (+10.69%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

Recommendations
Clorox point-of-sale data show acceleration, says DA Davidson » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
CLX

Clorox

$200.82 /

+1.21 (+0.61%)

DA Davidson analyst Linda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

11/03/20 RBC Capital
Clorox price target raised to $221 from $218 at RBC Capital
11/03/20 Deutsche Bank
Clorox price target raised to $227 from $223 at Deutsche Bank
11/03/20 Citi
Clorox price target lowered to $238 from $246 at Citi
10/16/20
Fly Intel: Top five analyst downgrades
CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.